{"id":50434,"date":"2020-07-06T00:31:35","date_gmt":"2020-07-06T00:31:35","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?post_type=faqs&p=50434"},"modified":"2020-11-19T17:04:56","modified_gmt":"2020-11-19T22:04:56","slug":"what-is-the-dot-panel-for-drug-testing","status":"publish","type":"faqs","link":"https:\/\/www.nationaldrugscreening.com\/faqs\/dot-drug-alcohol-testing-compliance\/what-is-the-dot-panel-for-drug-testing\/","title":{"rendered":"What is the DOT panel for drug testing?"},"content":{"rendered":"\n
Effective 01\/01\/2018 there is a new DOT 5 panel drug test. <\/p>\n\n\n\n
As specified in DOT regulations 49 CFR part 40 with the Cut Off levels listed in DOT regulations 49 CFR part 40; the following substances will be tested for:<\/p>\n\n\n\n
Some common names for the new semi-synthetic opioids include OxyContin\u00ae, Percodan\u00ae, Percocet\u00ae, Vicodin\u00ae, Lortab\u00ae, Norco\u00ae, Dilaudid\u00ae, and Exalgo\u00ae.<\/p>\n\n\n\n